REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Astrazeneca Singapore Pte Ltd (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Astrazeneca Singapore Pte Ltd Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Astrazeneca Singapore Pte. Ltd. is engaged in developing, manufacturing and marketing of prescription medicines. The company offers healthcare products for cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Astrazeneca Singapore Pte. Ltd. operates as a subsidiary of AstraZeneca PLC. The company was incorporated in 1990 and is based in Singapore.

Headquarters
10 Kallang Avenue, #12-10 Aperia, Singapore
Singapore; Singapore; Postal Code: 339510

Contact Details: Purchase the Astrazeneca Singapore Pte Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Astrazeneca Singapore Pte Ltd report to view the information.
Outstanding Shares:
Purchase the Astrazeneca Singapore Pte Ltd report to view the information.
Financial Auditors:
Purchase the Astrazeneca Singapore Pte Ltd report to view the information.
Incorporation Date:
May 23, 1990
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Astrazeneca Singapore Pte Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
29.9%▲
Total operating revenue
29.9%▲
Net Profit (Loss) for the Period
6.24%▲
Total assets
24.38%▲
Total equity
4.55%▲
Net Profit Margin
-0.57%▼
Return on Equity (ROE)
0.07%▲

Similar companies

Pfizer Asia Manufacturing Pte. Ltd.
 
Organon Asia Pacific Services Pte. Ltd.
Viatris Asia Pacific Pte. Ltd.
 
Edwards Lifesciences (Singapore) Pte. Ltd.
Amgen Singapore Manufacturing Pte. Ltd.
 
Cardinal Health Singapore 225 Pte. Ltd.
Hyphens Pharma International Limited
 
Baxter Healthcare (Asia) Pte Ltd
Wave Life Sciences Ltd.
 
Novartis (Singapore) Pte Ltd
Gke Corporation Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo